HomePRESS RELEASESMorphotek: Announces collaboration agreement with UW-Madison to study the immunosuppresive effects of...
Morphotek: Announces collaboration agreement with UW-Madison to study the immunosuppresive effects of CA125 tumor antigen on immune-based therapies for ovarian cancer